HALISTER: MORE: Actavis to Buy Allergan for $219/Shr in $66b Deal

MORE: Actavis to Buy Allergan for $219/Shr in $66b Deal

Alert: HALISTER Source: BFW (Bloomberg First Word)

Tickers ACT US (Actavis plc) AGN US (Allergan Inc/United States) VRX CN (Valeant Pharmaceuticals International Inc) BAYN GR (Bayer AG) JNJ US (Johnson & Johnson)

People Paul Bisaro (Actavis plc)

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283